These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29736708)

  • 21. Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.
    Okombo J; Chibale K
    Acc Chem Res; 2017 Jul; 50(7):1606-1616. PubMed ID: 28636311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging flow cytometry for the screening of compounds that disrupt the Plasmodium falciparum digestive vacuole.
    Chia WN; Lee YQ; Tan KS
    Methods; 2017 Jan; 112():211-220. PubMed ID: 27389304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay.
    Lee S; Lim D; Lee E; Lee N; Lee HG; Cechetto J; Liuzzi M; Freitas-Junior LH; Song JS; Bae MA; Oh S; Ayong L; Park SB
    J Med Chem; 2014 Sep; 57(17):7425-34. PubMed ID: 25137549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplasmodial activities of dyes against Plasmodium falciparum asexual and sexual stages: Contrasted uptakes of triarylmethanes Brilliant green, Green S (E142), and Patent Blue V (E131) by erythrocytes.
    Leba LJ; Popovici J; Estevez Y; Pelleau S; Legrand E; Musset L; Duplais C
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):314-320. PubMed ID: 28886443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication.
    Poonam ; Gupta Y; Gupta N; Singh S; Wu L; Chhikara BS; Rawat M; Rathi B
    Med Res Rev; 2018 Sep; 38(5):1511-1535. PubMed ID: 29372568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Overview of Currently Available Antimalarials.
    Gorobets NY; Sedash YV; Singh BK; Poonam ; Rathi B
    Curr Top Med Chem; 2017; 17(19):2143-2157. PubMed ID: 28137228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen.
    Tanaka TQ; Guiguemde WA; Barnett DS; Maron MI; Min J; Connelly MC; Suryadevara PK; Guy RK; Williamson KC
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1389-97. PubMed ID: 25512421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of inhibitors that dually target the new permeability pathway and dihydroorotate dehydrogenase in the blood stage of Plasmodium falciparum.
    Dickerman BK; Elsworth B; Cobbold SA; Nie CQ; McConville MJ; Crabb BS; Gilson PR
    Sci Rep; 2016 Nov; 6():37502. PubMed ID: 27874068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding the antimalarial toolkit: Targeting host-parasite interactions.
    Langhorne J; Duffy PE
    J Exp Med; 2016 Feb; 213(2):143-53. PubMed ID: 26834158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel approaches in antimalarial drug discovery.
    Held J; Kreidenweiss A; Mordmüller B
    Expert Opin Drug Discov; 2013 Nov; 8(11):1325-37. PubMed ID: 24090219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination.
    Reader J; Botha M; Theron A; Lauterbach SB; Rossouw C; Engelbrecht D; Wepener M; Smit A; Leroy D; Mancama D; Coetzer TL; Birkholtz LM
    Malar J; 2015 May; 14():213. PubMed ID: 25994518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity-oriented synthesis yields novel multistage antimalarial inhibitors.
    Kato N; Comer E; Sakata-Kato T; Sharma A; Sharma M; Maetani M; Bastien J; Brancucci NM; Bittker JA; Corey V; Clarke D; Derbyshire ER; Dornan GL; Duffy S; Eckley S; Itoe MA; Koolen KM; Lewis TA; Lui PS; Lukens AK; Lund E; March S; Meibalan E; Meier BC; McPhail JA; Mitasev B; Moss EL; Sayes M; Van Gessel Y; Wawer MJ; Yoshinaga T; Zeeman AM; Avery VM; Bhatia SN; Burke JE; Catteruccia F; Clardy JC; Clemons PA; Dechering KJ; Duvall JR; Foley MA; Gusovsky F; Kocken CH; Marti M; Morningstar ML; Munoz B; Neafsey DE; Sharma A; Winzeler EA; Wirth DF; Scherer CA; Schreiber SL
    Nature; 2016 Oct; 538(7625):344-349. PubMed ID: 27602946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
    Antonova-Koch Y; Meister S; Abraham M; Luth MR; Ottilie S; Lukens AK; Sakata-Kato T; Vanaerschot M; Owen E; Jado JC; Maher SP; Calla J; Plouffe D; Zhong Y; Chen K; Chaumeau V; Conway AJ; McNamara CW; Ibanez M; Gagaring K; Serrano FN; Eribez K; Taggard CM; Cheung AL; Lincoln C; Ambachew B; Rouillier M; Siegel D; Nosten F; Kyle DE; Gamo FJ; Zhou Y; Llinás M; Fidock DA; Wirth DF; Burrows J; Campo B; Winzeler EA
    Science; 2018 Dec; 362(6419):. PubMed ID: 30523084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity.
    Wicht KJ; Combrinck JM; Smith PJ; Egan TJ
    Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The therapeutic potential of metal-based antimalarial agents: implications for the mechanism of action.
    Biot C; Castro W; Botté CY; Navarro M
    Dalton Trans; 2012 Jun; 41(21):6335-49. PubMed ID: 22362072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRIMALDDI: platform technologies and novel anti-malarial drug targets.
    Vial H; Taramelli D; Boulton IC; Ward SA; Doerig C; Chibale K
    Malar J; 2013 Nov; 12():396. PubMed ID: 24498961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Nonartemisinin Sesquiterpene Lactones Parthenin and Parthenolide Block Plasmodium falciparum Sexual Stage Transmission.
    Balaich JN; Mathias DK; Torto B; Jackson BT; Tao D; Ebrahimi B; Tarimo BB; Cheseto X; Foster WA; Dinglasan RR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2108-17. PubMed ID: 26787692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical examination of approaches exploited to assess the effectiveness of transmission-blocking drugs for malaria.
    Wadi I; Anvikar AR; Nath M; Pillai CR; Sinha A; Valecha N
    Future Med Chem; 2018 Nov; 10(22):2619-2639. PubMed ID: 30499742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell based assays for anti-Plasmodium activity evaluation.
    Mokgethi-Morule T; N'Da DD
    Eur J Pharm Sci; 2016 Mar; 84():26-36. PubMed ID: 26776968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.